Evidence map›Paper›PMID 25520509›Full record

ArticleJournal of virology2015

Ataxia telangiectasia mutated kinase mediates NF-κB serine 276 phosphorylation and interferon expression via the IRF7-RIG-I amplification loop in paramyxovirus infection.

Ling Fang, Sanjeev Choudhary, Bing Tian, Istvan Boldogh, Chunying Yang, Teodora Ivanciuc, Yinghong Ma, Roberto P Garofalo, Allan R Brasier

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. IRF3 inhibits nuclear translocation of NF-κB to prevent viral inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Heat-killedThe Journal of international medical research · 2020
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ling FangDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.
Sanjeev ChoudharyDepartment of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA Sealy Center for Molecular Medicine, University of Texas Medical Branch, Galveston, Texas, USA Institute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas, USA.
Bing TianDepartment of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA Sealy Center for Molecular Medicine, University of Texas Medical Branch, Galveston, Texas, USA Institute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas, USA.
Istvan BoldoghSealy Center for Molecular Medicine, University of Texas Medical Branch, Galveston, Texas, USA Institute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas, USA Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Chunying YangDepartment of Radiation Oncology, Houston Methodist Research Institute, Weill Cornell University, Houston, Texas, USA.
Teodora IvanciucDepartment of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
Yinghong MaDepartment of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
Roberto P GarofaloSealy Center for Molecular Medicine, University of Texas Medical Branch, Galveston, Texas, USA Institute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas, USA Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
Allan R BrasierDepartment of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA Sealy Center for Molecular Medicine, University of Texas Medical Branch, Galveston, Texas, USA Institute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas, USA arbrasie@utmb.edu.
The University of Texas Medical Branch at Galveston · USCornell University · US

Funding

Virus, Tissue Culture and ImmunoassayP01AI062885 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI CASOLA, ANTONELLA · 2005 to 2022
$23.9M
Synthetic Organic Chemistry CoreP30ES006676 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ELFERINK, CORNELIS JOHAN · 1995 to 2017
$21.7M
UTMB Clinical and Translational Science AwardUL1TR000071 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2012 to 2014
$14.4M
NCATS NIH HHS UL1 TR000071NCATS NIH HHS UL1TR000071NHLBI NIH HHS HHSN268201000037CNIAID NIH HHS AI062885NIAID NIH HHS P01 AI062885NIEHS NIH HHS P30 ES006676
6 · The paper itself

Abstract

unlabelledRespiratory syncytial virus (RSV) is a primary etiological agent of childhood lower respiratory tract disease. Molecular patterns induced by active infection trigger a coordinated retinoic acid-inducible gene I (RIG-I)-Toll-like receptor (TLR) signaling response to induce inflammatory cytokines and antiviral mucosal interferons. Recently, we discovered a nuclear oxidative stress-sensitive pathway mediated by the DNA damage response protein, ataxia telangiectasia mutated (ATM), in cytokine-induced NF-κB/RelA Ser 276 phosphorylation. Here we observe that ATM silencing results in enhanced single-strand RNA (ssRNA) replication of RSVand Sendai virus, due to decreased expression and secretion of type I and III interferons (IFNs), despite maintenance of IFN regulatory factor 3 (IRF3)-dependent IFN-stimulated genes (ISGs). In addition to enhanced oxidative stress, RSV replication enhances foci of phosphorylated histone 2AX variant (γH2AX), Ser 1981 phosphorylation of ATM, and IKKγ/NEMO-dependent ATM nuclear export, indicating activation of the DNA damage response. ATM-deficient cells show defective RSV-induced mitogen and stress-activated kinase 1 (MSK-1) Ser 376 phosphorylation and reduced RelA Ser 276 phosphorylation, whose formation is required for IRF7 expression. We observe that RelA inducibly binds the native IFN regulatory factor 7 (IRF7) promoter in an ATM-dependent manner, and IRF7 inducibly binds to the endogenous retinoic acid-inducible gene I (RIG-I) promoter. Ectopic IRF7 expression restores RIG-I expression and type I/III IFN expression in ATM-silenced cells. We conclude that paramyxoviruses trigger the DNA damage response, a pathway required for MSK1 activation of phospho Ser 276 RelA formation to trigger the IRF7-RIG-I amplification loop necessary for mucosal IFN production. These data provide the molecular pathogenesis for defects in the cellular innate immunity of patients with homozygous ATM mutations. IMPORTANCE: RNA virus infections trigger cellular response pathways to limit spread to adjacent tissues. This "innate immune response" is mediated by germ line-encoded pattern recognition receptors that trigger activation of two, largely independent, intracellular NF-κB and IRF3 transcription factors. Downstream, expression of protective antiviral interferons is amplified by positive-feedback loops mediated by inducible interferon regulatory factors (IRFs) and retinoic acid inducible gene (RIG-I). Our results indicate that a nuclear oxidative stress- and DNA damage-sensing factor, ATM, is required to mediate a cross talk pathway between NF-κB and IRF7 through mediating phosphorylation of NF-κB. Our studies provide further information about the defects in cellular and innate immunity in patients with inherited ATM mutations.

Indexed as

Ataxia Telangiectasia Mutated ProteinsCell LineDEAD Box Protein 58DEAD-box RNA HelicasesEpithelial CellsGene SilencingHumansInterferon Regulatory Factor-7InterferonsNF-kappa BPhosphorylationProtein Processing, Post-TranslationalReceptors, ImmunologicRespiratory Syncytial VirusesRibosomal Protein S6 Kinases, 90-kDaSendai virusAtaxia Telangiectasia Mutated ProteinsATM protein, humanDEAD Box Protein 58DEAD-box RNA HelicasesInterferon Regulatory Factor-7InterferonsIRF7 protein, humanmitogen and stress-activated protein kinase 1NF-kappa BReceptors, ImmunologicRibosomal Protein S6 Kinases, 90-kDaRIGI protein, human

Identifiers

PMID25520509
PMCPMC4325710
OpenAlexW2105059571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.